We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-8.52%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$148M
AUM Growth
-$20.7M
Cap. Flow
-$4.64M
Cap. Flow %
-3.14%
Top 10 Hldgs %
59.53%
Holding
55
New
–
Increased
21
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$80.6K
2
MRK icon
Merck
MRK
+$74.6K
3
JNJ icon
Johnson & Johnson
JNJ
+$61.4K
4
BA icon
Boeing
BA
+$57.8K
5
ABT icon
Abbott
ABT
+$56.8K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$423K
2
AAPL icon
Apple
AAPL
+$404K
3
ET icon
Energy Transfer Partners
ET
+$375K
4
ILMN icon
Illumina
ILMN
+$362K
5
CELG
Celgene Corp
CELG
+$300K

Sector Composition

Rank Sector Weight
1 Healthcare 37.25%
2 Technology 24.31%
3 Consumer Discretionary 20.85%
4 Communication Services 10.06%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.96T
$17.5M 11.85%
635,204
-13,784
-2% -$404K
ILMN icon
2
Illumina
ILMN
$28.6B
$11.1M 7.54%
65,120
-1,789
-3% -$362K
CELG
3
DELISTED
Celgene Corp
CELG
$10.4M 7.06%
96,420
-2,418
-2% -$300K
GILD icon
4
Gilead Sciences
GILD
$167B
$10.3M 7%
105,306
-2,487
-2% -$276K
CTSH icon
5
Cognizant
CTSH
$23.8B
$8.27M 5.6%
132,144
-4,040
-3% -$254K
ISRG icon
6
Intuitive Surgical
ISRG
$131B
$7.06M 4.78%
138,294
-3,168
-2% -$179K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.02T
$6.66M 4.51%
214,400
-7,620
-3% -$234K
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$5.64M 3.82%
36,089
-820
-2% -$150K
META icon
9
Meta Platforms (Facebook)
META
$1.5T
$5.5M 3.72%
61,226
-868
-1% -$79.7K
CAVM
10
DELISTED
Cavium, Inc.
CAVM
$5.41M 3.66%
88,082
-2,206
-2% -$147K
ULTA icon
11
Ulta Beauty
ULTA
$21.5B
$5.4M 3.66%
33,083
-472
-1% -$77.7K
LULU icon
12
lululemon athletica
LULU
$13.8B
$5.05M 3.42%
99,761
-1,655
-2% -$101K
AMZN icon
13
Amazon
AMZN
$2.46T
$4.89M 3.31%
191,040
-2,460
-1% -$62.2K
SBUX icon
14
Starbucks
SBUX
$119B
$4.5M 3.05%
79,206
-2,282
-3% -$128K
VMW
15
DELISTED
VMware, Inc
VMW
$4.37M 2.96%
55,449
-1,356
-2% -$113K
VIPS icon
16
Vipshop
VIPS
$7.14B
$3.77M 2.55%
224,155
-2,835
-1% -$54.4K
BKNG icon
17
Booking.com
BKNG
$151B
$3.57M 2.42%
71,400
-900
-1% -$44.7K
ABBV icon
18
AbbVie
ABBV
$467B
$3.57M 2.41%
65,559
-1,251
-2% -$81.4K
BIIB icon
19
Biogen
BIIB
$29.8B
$3.23M 2.18%
11,061
-71
-0.6% -$23.4K
MDVN
20
DELISTED
MEDIVATION, INC.
MDVN
$2.36M 1.6%
55,630
-54
-0.1% -$2.67K
PRLB icon
21
Protolabs
PRLB
$1.8B
$2.27M 1.53%
33,857
+54
+0.2% +$3.85K
MELI icon
22
Mercado Libre
MELI
$95.1B
$2.22M 1.5%
24,356
+1
+0% +$118
BIDU icon
23
Baidu
BIDU
$35.4B
$2.05M 1.39%
14,894
-74
-0.5% -$12.2K
KMI icon
24
Kinder Morgan
KMI
$71.1B
$1.63M 1.1%
58,911
+343
+0.6% +$11.4K
TFM
25
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$1.04M 0.71%
46,146
-2,679
-5% -$72.7K
1
2 3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Bender Robert & Associates held 55 positions worth $148M, down 12% from $168M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Bender Robert & Associates withdrew a net $4.64M in Q3 2015, closing 6 positions and reducing 27 holdings. Its most notable exit was International Paper, an estimated $252K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bender Robert & Associates added an estimated $80.6K to Bristol-Myers Squibb.

  • Bender Robert & Associates added most to Bristol-Myers Squibb in Q3 2015, an estimated $80.6K increase.
  • Bender Robert & Associates's biggest Q3 2015 reduction was Eli Lilly, cutting an estimated $423K.
  • Bender Robert & Associates fully exited International Paper in Q3 2015, selling an estimated $252K.
  • Bender Robert & Associates's ten largest holdings make up 60% of its $148M portfolio in Q3 2015.
  • Bender Robert & Associates opened 0 new positions and closed 6 in Q3 2015.
  • Bender Robert & Associates's portfolio value fell 12% quarter-over-quarter to $148M.

Based on Bender Robert & Associates's 13F filing for Q3 2015, filed 29 Oct 2015.